I was drawn into "Is it time to abolish the patent system?" (by Professors David Levine and Michele Boldrin, Oct. 8) by the sheer number of failed arguments.
Contrary to their claims, the unavailability of AIDS drugs in Africa in the '90s and the recent Volkswagen scandal are not examples of patent law gone awry. They are examples of the exact opposite. By patenting a new drug in the U.S. and the EU, a pharmaceutical company can, in theory, charge patients in Africa a smaller price f...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In